Watchlist Price Alert

Reneo Pharmaceuticals Inc... (RPHM)

NASDAQ: RPHM · Real-Time Price · USD

18.20

16.47 (952.02%)

At close: Oct 04, 2024, 8:00 PM

Reneo Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-77.39M	-51.95M	-39.77M	-19.46M	-12.44M
Depreciation & Amortization	525K	88K	50K	37K	34K
Stock-Based Compensation	5.11K	4.32K	3.89K	393.00	388.00
Other Working Capital	12.22M	441K	-4.58M	-972K	527K
Other Non-Cash Items	2.01M	-774K	646K	-15K	673K
Deferred Income Tax	n/a	n/a	n/a	n/a	-2.73M
Change in Working Capital	12.22M	959K	-2.8M	514K	1.56M
Operating Cash Flow	-63.68M	-47.36M	-37.98M	-18.54M	-12.51M
Capital Expenditures	-221K	-346K	-198K	-24K	-7K
Cash Acquisitions	n/a	57.5K	23.18K	n/a	7.23K
Purchase of Investments	-231.26M	-101.6M	-31.41M	n/a	-19.83M
Sales Maturities Of Investments	242M	44.1M	8.23M	7.4M	12.6M
Other Investing Acitivies	10.74K	-57.5K	-23.18K	7.4K	-7.23K
Investing Cash Flow	10.52M	-57.84M	-23.38M	7.38M	-7.24M
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	-4.4M	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	730K	278K	556K	87K	26K
Financial Cash Flow	60.87M	471K	132.41M	47.27M	24.99M
Net Cash Flow	7.71M	-104.73M	71.05M	36.11M	5.24M
Free Cash Flow	-63.9M	-47.71M	-38.18M	-18.56M	-12.52M